Regulus Announces Addition to Board of Directors
Regulus Announces Addition to Board of Directors News provided by Share this article LA JOLLA, Calif., Jan. 27, 2021 /PRNewswire/ -- Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs, today announced Alice S. Huang, Ph.D. has been appointed to the Companys board of directors. Concurrently with her appointment to the Board, Dr. Huang was appointed to serve on the Compensation Committee. "We...
United States University Of Massachusetts Stelios Papadopoulos Alices Huang Johns Hopkins University National Foundation For Infectious Diseases
Source: prnewswire.com